TY - JOUR
T1 - Technical note
T2 - Delivery benefit and dosimetric implication of synchrotron-based proton pencil beam scanning using continuous scanning mode
AU - Liang, Xiaoying
AU - Beltran, Chris J.
AU - Liu, Chunbo
AU - Shen, Jiajian
AU - Li, Heng
AU - Furutani, Keith M.
N1 - Publisher Copyright:
© 2023 American Association of Physicists in Medicine.
PY - 2023/8
Y1 - 2023/8
N2 - Background: Discrete spot scanning (DSS) is the commonly used method for proton pencil beam scanning (PBS). There is lack of data on the dose-driven continuous scanning (DDCS). Purpose: To investigate delivery benefits and dosimetric implications of DDCS versus DSS for PBS systems. Methods: The irradiation duty factor, beam delivery time (BDT), and dose deviation were simulated for eight treatment plans in prostate, head and neck, liver, and lung, with both conventional fractionation and hypofractionation schemes. DDCS results were compared with those of DSS. Results: The DDCS irradiation duty factor (range, 11%–41%) was appreciably improved compared to DSS delivery (range, 4%–14%), within which, hypofractionation schemes had greater improvement than conventional fractionation. With decreasing stop ratio constraints, the DDCS BDT reduction was greater, but dose deviation also increased. With stop ratio constraints of 2, 1, 0.5, and 0, DDCS BDT reduction reached to 6%, 10%, 12%, and 15%, respectively, and dose deviation reached to 0.6%, 1.7%, 3.0%, and 5.2% root mean square error in PTV DVH, respectively. The 3%/2-mm gamma passing rate was greater than 99% with stop ratio constraints of 2 and 1, and greater than 95% with a stop ratio of 0.5. When the stop ratio constraint was removed, five of the eight treatment plans had a 3%/2-mm gamma passing rate greater than 95%, and the other three plans had a 3%/2-mm gamma passing rate between 90% and 95%. Conclusions: The irradiation duty factor was considerably improved with DDCS. Smaller stop ratio constraints led to shorter BDTs, but with the cost of larger dose deviations. Our finding suggested that a stop ratio of 1 constraint seems to yield acceptable DDCS dose deviation.
AB - Background: Discrete spot scanning (DSS) is the commonly used method for proton pencil beam scanning (PBS). There is lack of data on the dose-driven continuous scanning (DDCS). Purpose: To investigate delivery benefits and dosimetric implications of DDCS versus DSS for PBS systems. Methods: The irradiation duty factor, beam delivery time (BDT), and dose deviation were simulated for eight treatment plans in prostate, head and neck, liver, and lung, with both conventional fractionation and hypofractionation schemes. DDCS results were compared with those of DSS. Results: The DDCS irradiation duty factor (range, 11%–41%) was appreciably improved compared to DSS delivery (range, 4%–14%), within which, hypofractionation schemes had greater improvement than conventional fractionation. With decreasing stop ratio constraints, the DDCS BDT reduction was greater, but dose deviation also increased. With stop ratio constraints of 2, 1, 0.5, and 0, DDCS BDT reduction reached to 6%, 10%, 12%, and 15%, respectively, and dose deviation reached to 0.6%, 1.7%, 3.0%, and 5.2% root mean square error in PTV DVH, respectively. The 3%/2-mm gamma passing rate was greater than 99% with stop ratio constraints of 2 and 1, and greater than 95% with a stop ratio of 0.5. When the stop ratio constraint was removed, five of the eight treatment plans had a 3%/2-mm gamma passing rate greater than 95%, and the other three plans had a 3%/2-mm gamma passing rate between 90% and 95%. Conclusions: The irradiation duty factor was considerably improved with DDCS. Smaller stop ratio constraints led to shorter BDTs, but with the cost of larger dose deviations. Our finding suggested that a stop ratio of 1 constraint seems to yield acceptable DDCS dose deviation.
KW - beam delivery time
KW - dose deviation
KW - dose-driven continuous scanning
KW - proton beam therapy
UR - http://www.scopus.com/inward/record.url?scp=85158060858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85158060858&partnerID=8YFLogxK
U2 - 10.1002/mp.16434
DO - 10.1002/mp.16434
M3 - Article
C2 - 37115647
AN - SCOPUS:85158060858
SN - 0094-2405
VL - 50
SP - 5252
EP - 5261
JO - Medical physics
JF - Medical physics
IS - 8
ER -